Skip to main content
Premium Trial:

Request an Annual Quote

ABI Licenses Real-Time Thermal Cycler Patents to Eppendorf

NEW YORK, Nov. 14 (GenomeWeb News) - Applied Biosystems has granted Eppendorf a worldwide, royalty-bearing license to its real-time thermal cycler patents, ABI said last week.


The patents covered by the deal are US Patent No. 6,814,934 and foreign equivalents, ABI said.


According to ABI, Eppendorf will have the right to manufacture and sell real-time thermal cyclers in the research and applied fields.


Financial terms of the arrangement were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.